Newsroom
Zhifei Biological Jumped to AA in MSCI ESG Rating...
Zhifei Biological Jumped to AA in MSCI ESG Rating
2024-10-11
Recently, Chongqing Zhifei Biological Products Co., Ltd. (hereinafter referred to as "the Company", "Company", or "Zhifei Biological") recei...
see details 》
Zhifei Attends 2023 World Lung Health Conference and Visits World Heal...
Zhifei Attends 2023 World Lung Health Conference and Visits World Health Organization
2023-12-27
From November 15th to 18th, the Union World Conference on Lung Health, the most prestigious academic conference in the field of global tuber...
Zhifei and GSK reached strategic cooperation, adding a new blockbuster...
Zhifei and GSK reached strategic cooperation, adding a new blockbuster product
2023-10-12
On October 8, 2023, Chongqing Zhifei Biological Products Co., Ltd. (hereinafter referred to as "Zhifei") and GlaxoSmithKline (GSK Biologica...
Zhifei Initiated Phase II Clinical Trials of Recombinant 2019-nCoV Vaccine2020-07-10
On July 10, the Phase II clinical trials of recombinant 2019-nCoV vaccine jointly developed by Zhifei Longcom, a wholly-owned subsidiary of ...
The Recombinant 2019-nCoV Vaccine Approved for Clinical Trials2020-06-23
Recently, National Medical Products Administration has officially released the clinical trial notification for the recombinant 2019-nCoV vac...
Start a New Journey of Tuberculosis Prevention and Control after a Decade of Efforts2020-05-10
On May 10, 2020, Anhui Zhifei Longcom Biopharmaceutical Co., Ltd., a wholly-owned subsidiary of Zhifei, held a grand press conference on the...
Deng Xiangyang Visited Anhui Zhifei Longcom2020-04-18
On the morning of March 17, Deng Xiangyang, member of the Standing Committee of the Anhui Provincial Party Committee, executive vice governo...
Good News: Zhifei was Rated as a China’s AAA-Level Credit Enterprise2020-01-12
On January 12, 2020, the “2020 China Enterprise Credit Development Forum and the 11th Integrity & Public Welfare Ceremony” was held in Bei...